Jeffrey del Carmen Net Worth & Insider Trades
Jeffrey del Carmen - Chief Commercial Officer, Catalyst Pharmaceuticals, Inc
What is Jeffrey del Carmen's Net Worth?
The current estimated net worth of Catalyst Pharmaceuticals, Inc's Chief Commercial Officer, Jeffrey del Carmen, is estimated to be about $3.01M . Jeffrey del Carmen owns about 7,541 units of Catalyst Pharmaceuticals, Inc common stock. In the last 2 years at Catalyst Pharmaceuticals, Inc, Jeffrey del Carmen has sold an estimated value of $2.91M worth.
What is Jeffrey del Carmen's Past Insider Trading?
Jeffrey del Carmen's largest purchase order was 139,017 units , worth over $385.8K on November 15, 2022. Jeffrey del Carmen's largest sale order was 139,017 units , worth over $2.24M on November 15, 2022. In total, Jeffrey del Carmen has made about 10 transactions over 2 years of their time at Catalyst Pharmaceuticals, Inc. Jeffrey del Carmen usually trades in February, December and June, with the busiest year in 2022. The most recent transaction was a sale order of 40,000 units , worth over $667.81K on March 30, 2023.
Jeffrey Del Carmen
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jeffrey del Carmen's' Mailing Address?
- Mailing address is 355 Alhambra Circle Suite 801 Coral Gables FL 33134 FL
Catalyst Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|---|
| Patrick J. McEnany | 2018 | $524,236 | $332,063 | $ | $3,461,504 | $3,461,504 | $ | $3,461,504 |
| Steven R. Miller, COO and CSO | 2018 | $427,441409,325 | $188,600 | $ | $1,655,195 | $1,655,195 | $11,000 | $1,655,195 |
| Gary Ingenito, CM&RO | 2018 | $399,373 | $194,810 | $ | $1,666,645 | $1,666,645 | $26,192 | $1,666,645 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm
What are Catalyst Pharmaceuticals, Inc's Past Insider Trades?
Catalyst Pharmaceuticals, Inc's most recent insider trade came on May 17, 2023 by Patrick J McEnany who sold 26,151 units worth $345.98K . In the last 16 years, insiders at Catalyst Pharmaceuticals, Inc have sold an estimated value of $61.74M and bought an estimated value of $19.81M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Patrick J McEnany, President and CEO, Charles B. O'Keeffe, Director, and Philip H Coelho, Director .
CATALYST PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||